Variants of transmembrane 6 superfamily member 2 (TM6SF2) gene also confer the susceptibility to MASLD 44,45, and it remains to be determined whether TOP1MT SNPs are present in MASH patients 46. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.